Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods-Reference-Cited by-同舟云学术

Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods

Published:2008-02-15 Issue:4 Volume:111 Page:1774-1780
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Kantarjian Hagop¹,Schiffer Charles²,Jones Dan³,Cortes Jorge¹

Affiliation:

1. Departments ofLeukemia and

2. Wayne State University School of Medicine, Karmanos Cancer Institute, Division Hematology/Oncology, Detroit, MI

3. Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston; and

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/111/4/1774/1221024/zh800408001774.pdf

Reference61 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.;Druker;N Engl J Med,2006

2. Survival benefit with imatinib mesylate versus interferon alpha-based regimens in newly diagnosed chronic phase chronic myelogenous leukemia.;Kantarjian;Blood,2006

3. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.;O'Brien;N Engl J Med,2003

4. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia.;Guilhot;N Engl J Med,1997

5. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon.;Kantarjian;Ann Intern Med,1995

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02

2. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27

3. Chronic Myeloid Leukemia;Holland‐Frei Cancer Medicine;2022-10-21

4. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2022-07-06

5. Molecular Monitoring of BCR-ABL Fusion Transcripts in Patients with Chronic Myeloid Leukemia During Treatment Using the Endpoint Fluorescence Method;Laboratory Medicine;2021-09-15